Abstract This paper serves to fill a gap in the literature regarding evidence for the use of botanical remedies in the promotion of fertility. It examines the botanical remedies that were used in North America (1492-1900) for all stages of reproduction from preconception to birth, and discusses their potential for future use with present-day infertility treatments. Each medicinal plant discussed in this paper is assessed using an ethnomedicinal methodology that entails examining the published ethnobotanical, phytochemical and pharmacological data. A few clinical trials have shown that there is potential for medicinal plants to improve the success rate of assisted reproductive technology (ART) treatment if used in an integrated manner, similar to the integrated use of traditional Chinese medicine with ART treatment. For example, research has shown that older women who become pregnant have a high miscarriage rate, and this is one area that complementary and alternative medicines can address.
Introduction
In pre-20th century America, women relied on midwives, neighbours and homemade botanical remedies to support their reproductive health Drinker, 1991; England and Kramer, 1922; Leavitt, 1986; Tannenbaum, 2002) . (Allopathic medical knowledge of the time was suspect and expensive, and only used when traditional medicines failed (Frader and Stage, 1982; Ray, 2009 ). Dangerous substances like mercury were used, and doctors believed in harmful practices, such as bleeding, vomiting, blistering, purging, anondynes and so forth (Abrams, 2013; Douglass, 1854; Duffy, 1993; Haller, 1981; Ray, 2009) .
There are several medicinal plants that could be used in combination with assisted reproductive technology (ART) to lower the cost and increase the success rate of infertility treatment (Kooreman and Baars, 2012) . Using herbs in this way is not a new idea. As infertility treatment is expensive and has a low success rate -approaching 49% with cumulative attempts (Vrtacnik et al., 2014 ) -some women use medicinal plants to try to improve their odds of success without telling their doctor (Broussard et al., 2010) . Vitex was used by one woman who was undergoing in-vitro fertilization (IVF) treatment, and she showed signs of mild ovarian hyperstimulation (Cahill et al., 1994) . Pregnant women use medicinal plants to give them greater control over their experience, and this control improves birth satisfaction (Clark et al., 2013; Hall et al., 2012; Shannon et al., 2010; Smith et al., 2010; Westfall, 2001; Zeyneloglu and Onalan, 2014) . There are case reports of women who have become pregnant following alternative treatments. A 38-year-old Caucasian woman gave birth after being treated with Ayurvedic medicine in a German clinic. The treatment included some of the plants discussed later in this paper. The patient had secondary infertility of unknown cause, and had previously had 18 conventional fertility treatments in five different fertility centres in three different countries (Kessler et al., 2015) . However, most fertility specialists do not know or ask what plants their patients are using (Shannon et al., 2010; Zeyneloglu and Onalan, 2014) , and the testing of plant therapies in controlled trials is rare. However, there are some initial steps being taken towards an integrated approach in some clinics and in clinical trials. For example, Shahin et al. used black cohosh in combination with clomiphene citrate, and reported an increased clinical pregnancy rate for women under 35 years of age (Shahin and Mohammed, 2014; Shahin et al., 2008 Shahin et al., , 2009 ). These clinical trials are discussed later in the paper.
The argument put forward in this paper is two-pronged: (i) women are already using traditional botanical remedies, with or without the consent or knowledge of their doctors (Hall et al., 2012; Shannon et al., 2010; Smith et al., 2010 ) -this paper examines the published phytochemical and pharmacological data on the plants that are being used to assess their safety and efficacy; and (ii) there are potential benefits to examining plants that have been used for centuries by Native Americans, or that came to America through European immigration, or that have a basis in historical Greek or Arabic medical treatises, such as opopanax (Opopanax chironium), asafoetida (Ferula assa-foetida) and others. There is anecdotal and other evidence that at least some of the biochemically active compounds in the plants that have been used traditionally could serve as adjuncts to fertility treatments, potentially reducing costs by raising efficacy and offering hope and help to women barred from accessing ART treatment due to variable age and cost limits in different countries.
The most promising areas for the use of botanicals in improving livebirth rates are: (i) age-related decreased ovarian reserve (≥40 years of age), (ii) stress associated with subfertility (oxidative stress or linked to increased prolactin levels), (iii) luteal-phase defects, and (iv) increased rate of miscarriage for older women receiving ART because fertility declines with age and the demand for IVF typically increases with age. If herbs can increase the success rate of ART by preventing miscarriages and improving implantation rates, for example, this would lower the cost of ART.
This paper identifies the sources of herbal remedies in North America up to 1900, describes evidence for their effectiveness and any side effects, and examines how the use of plants may help ART.
Materials and methods
An ethnomedicinal validation technique is used in this paper to identify traditional medicines with contemporary value. Validation includes examining the published phytochemical and pharmacological data to establish whether or not the reported folk use of plants is safe and effective (Lans et al., 2003) . As this is a search for potential plant compounds to be used in future clinical trials and a historical study, exclusion criteria were not used in the validation process for the literature reviewed in this paper. Many of the books and journals used from 1492 to 1900 have been digitized, and these were searched online for terms related to reproductive problems; the plants used to treat patients with the noted condition were recorded. In most cases, these documents were patient reports, discussions of newly analysed plant compounds, or discussions of new patent medicines based on newly discovered North American plants. The databases used for the validation of the plants were ScienceDirect, PubMed and Scopus. The databases JSTOR and ProjectMUSE were also searched, but yielded little information.
The dates for the time periods relevant to this paper are listed by the Gilder Lehrman Institute of American History (https://www.gilderlehrman.org/history-by-era/earlyrepublic/essays/early-republic), as follows: Culpeper, 1955) . Schiebinger (2004) describes an abortifacient provided in a medieval midwifery manuscript, and notes that midwives began writing more books in the 17th century but they were mainly polemics about male midwives. The pseudoAristotelian works such as Aristotle's Masterpiece contained useful gynaecological information and practical advice on pregnancy, conception and childbirth, but these were mainly read by men as pornography and aids to seduction (Hayes, 1996) .
Dr. Thomas Williams was born in Newton, Massachusetts in 1718 and died in Deerfield in 1775. Dr. Williams' collection of papers contains a 28-page, personally copied book by William Salmon, MD, entitled The English Herbal: of History of Plants (Pollock, 2009; Salmon et al., 1710) . The text is an alphabetical listing of medicinals in addition to definitions, qualities, applications and formulation recipes. Salmon (1644-1713) was an untrained English doctor practising near the gates of St Bartholomew's Hospital in London. A New Jersey physician with a large practice, and therefore some available wealth, paid the cost of a messenger to England to obtain the volume, which he then used from 1758 to 1777 (Stackhouse, 1908) . This is one example of how books arrived in the USA and how one doctor copied and adapted available literature for his own practice. John Josselyn of Essex published New England's Rarities Discovered in 1672. Josselyn carried with him the 1633 edition of Gerard's Herball or Generall Historie of Plantes that he used to help identify plants (Vogel, 1970) , providing another example of a book being taken to the USA.
The medicinal botanical guides by John Bartram and his son, William Bartram were another source of information. These guides included Native American remedies learned during plant-collecting trips across the eastern colonies of America and Ontario. These guides, including True Indian Physic, or Ipecacuanha, were published in the 1741 American Almanac in Philadelphia by John German and in Benjamin Franklin's 1741 Poor Richard's Almanack (Ray, 2009) . Poor Richard's Almanack and other almanacks also conveyed information from African-Americans (for poison and snakebite cures) (Hayes, 1996) . One-third of colonial families bought an almanack annually (Tannenbaum, 2012 (Bartram and Squier, 1853; Bell, 1975; Klepp, 2001; Murphy, 1991; Ray, 2009; Rosenberg and Helfand, 1998; Rothstein, 1985 Plantes (Blunt and Raphael, 1994; Kay, 1996) . Owing to these translations and compilations, we now know that some of the plants used in pre-20th century America have been used since ancient times (Ambrosini et al., 2013) .
Medical almanacs of two female authors of 17th century England, Sarah Jinner of London and Mary Holden of Sudbury, transmitted classically-based medical cures for women. Jinner's almanac informed women about abortifacient and emmenagogic drugs from Galen and Hippocrates (Weber, 2003) . Of more than 200 plants in his works, Hippocrates lists 44 plants with gynaecological uses; more than any other category and more devoted to treatment than the non-gynaecological uses, which are more theoretical (Touwaide and Appetiti, 2015) .
Avicenna's Canon of Medicine was used in medical studies across Europe and Asia from the 12th century until the beginning of the 18th century (Modanlou, 2008) . Avicenna wrote the Canon because "The ancient Hippocratic corpus was enigmatic, Galen prolix, Rāzī confusing… neither the Greeks nor the Arabs had any book that could teach the art of medicine as an integrated subject" (Shoja et al., 2011) . Avicenna had rules for testing drugs that suggest clinical experience and experimentation (Shoja et al., 2011) . A brief history of herbals and other texts (see Supplementary Material Item 1) indicates that the latest editions of Culpeper and Avicenna should be sufficient for researchers who want to investigate which botanical remedies could be used in combination with ART in an integrated way. It also indicates that many plant uses are common across Europe, America and parts of the Arab world, and would be culturally acceptable to patients in those areas.
The Arthur and Elizabeth Schlesinger Library on the History of Women in America at Harvard University houses the records of 19th century entrepreneur Mrs. Lydia Pinkham (1819-1883). As a young woman, she worked as a midwife, nurse and schoolteacher. In 1873, Pinkham founded the Lydia E. Pinkham Medicine Company in order to market the herbal medicine, Lydia E. Pinkham's Vegetable Compound that her husband had received as payment for a debt (Conrad and Leiter, 2008) . After using it for the health problems of her immediate circle of family, friends and neighbours, her son convinced her to advertise and sales increased. Her vegetable compound and emmenagogues were sold to women with various ailments, including delayed menstruation, fallen womb and inflammation of the uterus (Frader and Stage, 1982; Young, 1980) . The compound contained 20% alcohol, 8 oz. unicorn root (Aletris farinosa), 6 oz. of liferoot (Senecio aureus), 6 oz. of black cohosh (Actaea racemosa), 6 oz. of pleurisy root (Asclepias tuberosa) and 12 oz. of fenugreek seeds (Trigonella foenum-graceum), all macerated (Stage, 1979) . Other compounds included liquorice root (Glycyrrhiza glabra), dandelion root (Taraxacum officinale), gentian (Gentiana catesbaei), helonias/false unicorn root (Helonias dioica), matricari/ chamomile flowers (Matricaria chamomilla) and thiamine hydrochloride (vitamin B1 The label of Lydia Pinkham's compound described female weaknesses as leucorrhoea, irregular and painful menstruation, inflammation and ulceration of the womb. Her business expanded to reap profits of $300,000 annually, and the production of the compound switched from her kitchen and cellar to a laboratory. Part of the reason for her success was that doctors advocated removal of the ovaries for vaginal cramps, and this surgery had a mortality rate of 40% (http:// ocp.hul.harvard.edu//ww/pinkham.html). The plants in Pinkham's formulation and their properties were discussed in The Lancet (Anon, 1863) . Unicorn root (Aletris farinosa) was described as a tonic in small doses and an emetic in large doses. Aletridin, a precipitate of the plant, was said to be a uterine tonic. Senecionin, a tincture made from the leaves and roots of various liferoot (Senecio) species including Senecio aureus, was sold as an emmenagogue, and it was reported to tone the uterus and restore menstruation (Anon, 1863) . Bethroot (Trillium pendulum) was used to promote parturition, and was recommended for haemorrhage, menorrhagia and leucorrhoea. Pharmacists Bradley and Bourdas wrote in a letter to the editor of The Lancet that they had Trillium pendulum for sale as a "remedial agent" for "uterine diseases"... "any gentleman who may wish to try its effects can be supplied with it" (Notices to Correspondents, The Lancet London, 18 July 1863, p. 87). This letter was written in response to the discussion of the plants listed in Pinkham's formulation in The Lancet (see Anon, 1863) . One of the plants listed as understudied in this paper, Piscidia piscipula, was used only in Pinkham's formulation. Asclepias tuberosa and Helonias dioica were not often found in the literature associated with reproductive problems. One can only speculate that Pinkham's 1876 patent made further investigations of these plants uninteresting.
Botanical remedies used for reproductive health before 1900
The following section examines the botanical remedies that were used to support the reproductive health of American women before 1900. Emmenagogues, contraceptives and abortifacients are most commonly found in the historical documentation that is available today. Also common are herbs used as uterine tonics and herbs used to induce labour. Less common are herbs that specifically enhance fertility. All the various categories will be discussed as it is unknown at this time which plants will prove useful for combined therapy with ART.
Women's gynaecological practices in North America pre-1900
Uterine tonics used early in the Colonial Period were either ancient herbal remedies or toxic chemicals. These uterine tonics included various salts of iron (possible adverse effects), bromide of potassium (an anticonvulsant), bi-tartrate of potass (increased potassium in the body can cause heart or kidney problems) and various phosphates (toxic) (The Lancet, 1863). The ancient herbal tonics were myrrh (Commiphora myrrha), savin (Juniperus sabina) and ergot (Claviceps purpurea) (The Lancet, 1863). The newly introduced American uterine herbal tonics were blue cohosh (Caulophyllum thalictroides), black cohosh (Actaea racemosa), unicorn root (Aletris farinosa), butterfly weed (Asclepias tuberosa), squaw weed (Senecio gracilis) and bethroot (Trillium pendulum), most of which were non-toxic. These tonics will be discussed later in the paper.
Women took care of the health of their households by relying on several books, including the many editions of William Buchan's Domestic Medicine printed in the UK and the USA (Buchan et al., 1772) . Some of these books are listed in Supplementary Material Item 1).
Botanical remedies used historically in women's reproductive health
American scientists and medical practitioners working before 1900 were open to blending indigenous medicinal plants into a pharmacopoeia that relied heavily on the herbals described above and on more informal ones (see Supplementary Material Item 2). Medical practitioners in Britain and America shared the knowledge of the newly discovered Native American plants such as black cohosh (Actaea racemosa) and black haw (Viburnum prunifolium) for dysmenorrhoea (pain during menstruation) at medical meetings and in journals (Royal Academy of Medicine in Ireland, 1900).
Household slaves served as informal medical practitioners in some homes (Tannenbaum, 2012) . Granny midwives attended childbirths on some slave plantations as a cost-saving measure for the owners, but sometimes acted as abortionists (Vaughan, 1997) . Vaughan (1997) records the plants or plant-based products used by slaves to abort, and several are discussed in this paper: tansy, catnip, thyme, horse mint, rue, pennyroyal, cedar berries, Origanum vulgare, Thuja occidentalis, oil of savin, leaves of Juniperus virginiana, fruit of Juniperus communis, Cimcifuga racemosa, Caullophyllum thalictroides, Actea rubra, Helleborus viridis, Leonotis leonurus, Trillium undulatum, Trillium sessile, Trillium erectum and Cunila origanoides. Scudder (1870) was told by several parties that planters forced their slaves to drink an infusion of viburnum tonic daily whilst pregnant. This tonic maintained their pregnancies even though they used cotton root (Gossypium herbaceum) to try to abort their pregnancies. A physician from Texas reported that he had observed this anti-abortive use of the plant for 15 years, and that he had prescribed it in many cases without a failure (Scudder, 1870) .
Blue cohosh (Caulophyllum thalictroides) was listed in the United States Pharmacopoeia between 1882 and 1905 as a labour inducer (Dugoua et al., 2008) , copying Native Americans who used it to relieve menstrual cramps and ease childbirth pains. "Cohosh" is said to mean "pregnancy" in the Algonquian language (Johnson and Fahey, 2012) . Indian uses of the plant became known to botanists through an irregular publication entitled The Indian Doctor's Dispensatory issued in Cincinnati in 1812 by Peter Smith (Lloyd, 1898) . Peter Smith was born in Wales, educated at Princeton and, as an adult, collected information from physicians whom he met in New Jersey, Pennsylvania, Virginia, North and South Carolina, Georgia, Kentucky and Ohio while he travelled with his young family as a preacher (Lloyd, 1898) . Disapproving of slavery, he left the slave states of the South and moved to Ohio. In Smith's words: "… I have incidentally obtained a knowledge of many of the simples used by the Indians…". Native Americans explained plant medicine to Smith as "This thing is good for that thing; this medicine will cure that complaint" (Smith, 1812) .
Black haw (Viburnum prunifolium) was discussed in The Lancet of 1888 as being valuable because there was no known substitute for the American plant. The Lancet noted that Viburnum prunifolium had a "reputation as an ovarian and uterine anodyne", and stated that it was "used in amenorrhoea and menorrhagia" and "gave excellent results in the treatment of dysmenorrhea, after-pains and ovarian irritation and disposition to miscarriage", although others disputed this. Viburnum was used for pregnancy pains. For this indication, it was recommended to be taken regularly for a long time. There was also discussion of a case in which viburnum was believed to have held a fetus, which was not known to be dead, in the uterus for months until it was aborted (Pharmacology and Therapeutics, 1888) . Other plant uses are listed below.
Validation of plants used for fertility enhancement
This section considers the safety and effectiveness of herbal remedies used for fertility enhancement by examining the phytochemical and pharmacological data for any scientific basis for the potential use of plant-derived compounds to prevent miscarriage and to delay the decrease in ovarian follicles in women aged 40 years or older.
Predisposing factors for infertility in women include amenorrhoea (absence of menstrual period), oligomenorrhoea (irregular menstruation) and pelvic inflammatory disease (infection of the reproductive organs). Dysmenorrhoea linked to endometriosis is the cause of infertility in 30-50% of women with the condition (Bulletti et al., 2010) . Secondary dysmenorrhoea (linked to endometriosis, uterine fibroids and ovarian cysts) can lead to infertility or ectopic pregnancies (Bulletti et al., 2010) . The colonial term "delayed menses" typically means amenorrhoea due to stress, poor nutrition, overwork or early pregnancy. Hippocrates believed that untreated amenorrhoea was fatal (Warren and Fried, 2001) . Stress, poor diet and overexercising are some of the factors that can result in amenorrhoea (Meldrum, 2013; Wu et al., 2015) . Amenorrhoea and oligomenorrhoea make it difficult to detect ovulation, if it takes place at all, leading to infertility. Emmenagogues have traditionally been used to stimulate menstruation; in some cases, they may be used to cause an abortion surreptitiously (Riddle, 1992) .
Fertility for both sexes declines slowly after 30 years of age and more rapidly after 40 years of age, and age is considered to be the main limiting factor in treating infertility. Normally, 75% of women trying to conceive at 30 years of age will give birth within 1 year, compared with 66% at 35 years of age and 44% at 40 years of age. The conception rates over a 4-year timespan are 91%, 84% and 64%, respectively (Baird et al., 2005) . The most important reason for decreased fecundity is the decrease in the population of ovarian follicles, and a decline in ovarian hormone production beginning before 40 years of age. Also, insulin-sensitive patients have a greater decline of follicle-stimulating-hormone-sensitive antral follicles as diabetes creates oxidative stress (Bentov and Casper, 2013) . The ageing of the reproductive organs does not occur until 50 years of age, brought on by reduced uterine blood flow, progesterone-related effects or an increase in the number of fibroids (Ng and Ho, 2007) . This is why donor oocytes from young women are often recommended to older women (Baird et al., 2005; Bentov and Casper, 2013) , and why donor-egg pregnancy rates decline after 50 years of age.
Botanical remedies that can potentially reduce or reverse genetic damage
The fertility-boosting potential of some plants can be linked to their antioxidant properties. Oxidative stress linked to aging results in the decreased production of glutathione and a negative impact on the granulosa cells that nourish the oocyte (Meldrum, 2013; Wu et al., 2015) . In older women, there are increases in cortisol level, and changes in luteinizing hormone and growth hormone (Ben-Meir et al., 2015; Ng and Ho, 2007) . Some of these processes can be reversed with antioxidants, including those found in medicinal plants (Table 1) .
Asarum canadense contains quercetin glucosides (Iwashina and Kitajima, 2000; Schaneberg and Khan, 2004) . Helleborus niger contains a quercetin glycoside (Vitalini et al., 2011) . Chinese liquorice (Glycyrrhiza uralensis) has quercetin in its leaves (Duke et al., 1994) . Quercetin is an antioxidant that improved the in-vitro development of porcine oocytes by reducing the levels of reactive oygen species (ROS) (Kang et al., 2013) . Quercetin also reduced the ROS in chilled stored rabbit sperm (Johinke et al., 2014) . Quercetin has an antiabortive effect in mice, and acts by reducing the overproduction of tumour necrosis factor-alpha and nitric oxide, and by maintaining the balance of CD4 +/CD8 + T lymphocytes and the cytokine interferon-γ/interleukin-4 balance in the uterus . Leonurus cardiaca contains chlorogenic, cafferic and ferulic acid and phenylethanoids that scavenge ROS (Flemmig et al., 2015) . A few of the plants contain vitamins (Aralia nudicaulis, Juniperus communis). Taking multivitamins was associated with decreased pregnancy loss in a prospective cohort study in the USA with preconception enrolment (Buck et al., 2016) .
A more systematic approach to tackling the aging oocyte and diminishing ovarian reserve may lie in the practice of Chinese medicine that prepares the whole body for pregnancy. This would be useful for all ART patients. Patients could continue to be treated with this whole-body traditional Chinese medicine (TCM) that appears to reset the body organs to normal functioning. Endometriosis associated with infertility has been diagnosed in TCM as kidney deficiency and blood stasis, and the TCM treatment is designed to address those underlying conditions first rather than sending the patient straight for ART treatment (Ding and Lian, 2015) . Other Chinese medicine diagnoses are called "tonification of the kidney system and of the spleen, qi tonification of the liver blood and heart blood, and harmonization of the liver…" which "roughly corresponds to anovulation patterns, thin endometrial lining and poor ovarian quality due to age" (Sela et al., 2011) .
A detailed review of TCM diagnosis of syndromes associated with diminished ovarian reserve (DOR) is provided in Zhang and Xu (2016) . The blood, liver, heart, kidneys, speen and lungs are all checked and treated if necessary to ensure that the entire body is ready for implantation. Artemisia argyi was one of the plants used in a multicomponent formula for DOR. Angelica sinensis was used in another treatment for DOR during the luteal phase. Cao et al. (2013) point out that Angelica sinensis was used in 15 of the 20 trials that they evaluated. The 20 trials investigated whether Chinese herbal medicine (including decoctions and granules) could improve the clinical (or laboratory) outcomes of IVF compared with IVF alone (see Supplementary Material Item 31). This paper has focused on specific uses of plants for infertility treatment, and does not recommend their longterm use. Some plants could be used together with IVF or intrauterine insemination treatment; others would be used to support any resulting pregnancy according to the needs of the individual patient. Tailoring treatment to individual needs is the practice in Chinese medicine (Sela et al., 2011) . For clinical trials of plants, it may be necessary to group patients into infertility groups with similar causes, such as luteal-phase defect or polycystic ovary syndrome (PCOS), to test specific plants. This is especially necessary to ensure that there are no adverse effects (Boivin and Schmidt, 2009) , or null effects for older women .
Plants for further investigation
The validation process established that all the plants used historically for reproductive problems could be used in an integrated way with ART, and merit further study. Below is an evaluation of the most-studied plants. These plants may 
Sweet flag (Acorus calamus)
Acorus gramineus Soland ("shi chang pu") (same plant family as Acorus calamus) and glycyrrhiza ("gan cao") (part of Deborah Read's formula in the Supplementary Material) are used in multicomponent remedies in TCM to treat both sexes (Ding and Lian, 2015; Tempest et al., 2008) .
Black cohosh is widely used to treat symptoms of menopause, and a number of clinical investigations have verified its effectiveness as a supplement to or substitute for hormone replacement therapy (Blumenthal, 2000; Kessel and Kronenberg, 2004) . Black cohosh is currently used in allopathic medicine, but it is only indicated for menopause-related neurovegetative and emotional symptoms (Schellenberg et al., 2012) . The German Commission E approved black cohosh treatments for premenstrual syndrome, dysmenorrhoea and menopausal symptoms (Fritz et al., 2014) . Dog et al. (2010) list the herb-drug interactions for black cohosh and the current regulatory requirements for its active compounds.
Black cohosh may cause gastrointestinal problems if used long term (Elvin-Lewis, 2001); however, this adverse effect needs to be evaluated against the claims that black cohosh prevented bone loss and bone marrow fat accumulation in ovariectomized rats (Schilling et al., 2014; Soni et al., 2011) . Midwives have reported adverse effects from black cohosh. Wuttke et al. (2014) claim that many commercial preparations have Asian varieties of black cohosh (Cimicifuga racemosa, "sheng ma") which contain different chemical constituents from North American varieties, and the Asian varieties have been less studied, but adverse reactions to black cohosh in Canada were claimed to be due to the use of the Asian species (Actaea cimicifuga; Dog et al., 2010) . Sheng ma is indicated for headache and digestive distress, and is not typically used to treat infertility in TCM.
Angelica (Angelica archangelica)
Angelica gigas Nakai and Angelica sinensis (Oliv.) Diels ("dang gui") (in the same plant family as Angelica archangelica) are used in multicompound Chinese medicine remedies to treat infertility (Ding and Lian, 2015; Zhang and Xu, 2016) . Dang gui is commonly known as "the women's herb" and is indicated for many different kinds of gynaecologic disorders in TCM. However, its use is not limited to women's concerns, as dang gui is used in many multicompound Chinese herbal formulas to treat male factor infertility, including improving sperm motility, morphology and count . The possibility of adulturation has to be taken into account when reading reports of liver toxicity for Angelica archangelica (Teschke et al., 2014) . Angelica glauca was part of the multiplant treatment used by Kessler et al. (2015) . Archangelica officinalis is a synonym of Angelica archangelica L. (Apiaceae).
Blue cohosh (Caulophyllum thalictroides)
Midwives have reported adverse effects from blue cohosh such as nausea, increased meconium-stained fluid and transient fetal tachycardia. Case reports of health problems in newborns associated with maternal use of blue cohosh are possibly due to caulosaponin and caulophyllosaponin, constituents of blue cohosh that cause coronary blood vessel constriction, a toxic effect on cardiac muscles and myocardial toxicity (Gunn and Wright, 1996; Jones and Lawson, 1998) . The mother in the adverse case report had been advised by the midwife to take one blue cohosh tablet per day for 1 month prior to delivery to help induce uterine contractions. The mother elected to take three times the dose for 5 weeks. She had increased contractions and a decrease in fetal activity. The delivery took 1 h. The infant required intubation after 20 min and had cardiogenic shock caused by myocardial ischaemia, was critically ill for several weeks, but survived (Elvin-Lewis, 2001; Jones and Lawson, 1998) .
Chelidonium majus
Chelidonium majus is used in TCM ("bai qu cai") to treat PCOS. In a single-arm pilot study, 0.4 g berberine was given three times per day for 4 months to 102 anovulatory Chinese women with PCOS, and 14 women restarted regular menses (Li et al., 2015) . [Berberine is found in Chelidonium majus; see multiplant formula listed for Populus tremuloides in the dosage listed below (Supplementary Material Item 24) ]. Ten women taking Chelidonium majus for 3 months (which we are not recommending) showed liver injury (elevated serum alanine aminotransferase and alkaline phosphatase, but no liver failure) (Bunchorntavakul and Reddy, 2013) . A study on the swine uterus (Sus scrofa domesticus) compared butylscopolamine (hyoscine butylbromide, Buscopan, derived from Atropa belladonna), atropine (Belladonnysat Bürger, derived from Atropa belladonna, Hyoscyamus niger and Datura stramonium), denaverine (Spasmalgan), celandine (Chelidonium, Paverysat), pethidine (Dolantin, Demerol), morphine (Paveriwern, derived from Papaver somniferum) and metamizole (Novaminsulfon-ratiopharm). Celandine (found in Chelidonium majus) caused contractions in uterine muscle and may promote rapid sperm transport (Kuenzel et al., 2013) .
Skullcap (Scutellaria baicalensis) (Lamiaceae)
Skullcap was part of the Dioviburnia cordial made by Dios Chemical Co., of St. Louis, Missouri (Shrady, 1891) . Skullcap ("huang qin") is one of the top 40 herbs in TCM herbology, and is used in herbal combinations for a wide variety of gynaecologic and obstetric conditions. It is also used in herbal formulas to prevent miscarriage and to stop metrorrhagia. The main chemical constituents of huang qin are baicalein, baicalin, wogonin, wogonoside, neobaicalein, acetophenone, An active oxytocic compound that is responsible for increasing uterine tone; it contains quinolizidine alkaloids (anagyrine (teratogenic), baptifoline, n-methylcytisine) (nictotinic), aporphine alkaloids (magnoflorine, taspine, boldine), norlupanine alkaloids (sparteine, cytisine, lupanine), piperidine alkaloids (thalictroidine, caulophyllumines A and B), steroidal glycosides and several triterpene glycosides Matsuo et al., 2009; Rader and Pawar, 2013 Adverse effects from overdose -nausea, increased meconiumstained fluid and transient fetal tachycardia
Caulosaponin and caulophyllosaponin, constituents of blue cohosh that cause coronary blood vessel constriction, toxic effect on cardiac muscles and myocardial toxicity Elvin-Lewis, 2001; Gunn and Wright, 1996; Jones and Lawson, 1998 palmitic acid, oleic acid, proline, benzoic acid, radix scutellariae enzyme and β-sitosterol. Its decoction in vitro has various degrees of inhibition on various bacteria. It also reduces fever, lowers blood pressure, protects the liver and gallbladder, inhibits intestinal motility, lowers lipids, resists oxidation, regulates cAMP levels and fights tumours. The possibility of adulturation has to be taken into account when reading reports of liver toxicity for Scutellaria baicalensis (Teschke et al., 2014) .
Liquorice (Glycyrrhiza uralensis) (Fabaceae)
Liquorice (Glycyrrhiza uralensis) (Fabaceae) was part of Deborah Read Franklin's formula (see Supplementary Material) and Lydia Pinkham's formula discussed above. IVF success in mice improved with the addition of a water extract of Glycyrrhiza uralensis to the artificial insemination culture medium. Adding glycyrrhizic acid was not successful (Tung et al., 2015) . The relevant compounds are isoliquiritigenin and formononetin. Isoliquiritigenin may be metabolized to form liquiritigenin, which is an active flavonoid. Isoflavones such as formononetin can improve impaired oestrous cycling, ovarian function, and functions of the hypothalamus and pituitary gland (Tung et al., 2015) . Adverse effects are seen with doses of liquorice above 600 mg/day and it is not recommended for long-term use (Tovar and Petzel, 2009 ). An ovarian counterpart of glycyrrhiza acts as an inhibitor of glucocorticoid metabolism (in common with liquorice) by 11βHSD, and has a positive effect on the ability of an embryo to develop and implant by affecting the cortisol:cortisone ratio (Michael, 2003) . 11βHSD in the placenta reduces fetal exposure to maternal glucocorticoids (van Uum et al., 1998).
Rue (Ruta graveolens) Rutaceae
Slaves used rue (Ruta graveolens) to abort and it was used for suppressed menses either alone or in combination with tansy (Tanacetum parthenium), savin (Juniperus sabina) and pennyroyal (Mentha pulegium) (Riddle, 1992; Vaughan and Clark Atlanta University, 1997) . Some reports of Ruta graveolens (and pennyroyal) being used for abortions fall into the category: 'her bereaved relatives rued the day she ever used that plant' (Ciganda and Laborde, 2003) . The mouse trial conducted by de Freitas et al. (2005) suggests that Ruta graveolens had little or no negative effects in early pregnancy, but there were negative effects in the later stages of pregnancy. 
Discussion
This ethnomedicinal examination has documented a scientific basis for the folk use of some herbs, while clinical evidence is lacking in other cases. This is typically due to the fact that many of the herbs have not been studied at all in a clinical setting, rather than their effectiveness having been disproved. Anything that helps treat the infertile more effectively is needed. The global provision of ART corresponds to only 20% of the demand in developed countries and 1% of the estimated demand in developing countries (Collins, 2002) . IVF costs are 50% higher than the gross national income per capita of most developing countries (Vayena et al., 2009) , and greater than 50% of the average annual disposable income in the USA (Quinn and Fujimoto, 2016 ($42,491) and the 8% of non-Hispanic black women ($35,398) . The ability to build a family using infertility services in the USA has been described as a "function of economic prowess" (Adashi and Dean, 2016). Moroever, women seeking IVF are facing age restrictions everywhere. For example, the Czech Republic is preparing a new act to regulate ART with an age limit of 45 years for women, but with no limit for Czech men (Kocourkova et al., 2015) . Of the 73,406 IVF cycles initiated in the USA in 2000, 6989 (9.5%) were performed in women aged over 40 years, for whom the livebirth rates for 1996 , 1998 , 1999 were 6.4%, 7.3%, 8.3%, 8.1% and 7.8%, respectively (Ng and Ho, 2007 . Quebec publicly funds IVF treatment and proposed a ban on women aged over 42 years from seeking treatment even outside the province (Dyer, 2014) ; it has kept the ban on public funding for women aged over 42 years but allows them to pay, thus making it unaffordable for poorer people (Weeks, 2015) . In France, ART is free of charge in public hospitals for women until 43 years of age (Belaisch-Allart et al., 2015) . Singapore has a cofunding scheme for couples, which provides partial financial reimbursement to women under 40 years of age undergoing a maximum of three fresh and three frozen ART cycles in public hospitals. The scheme is based on cost-effectiveness and women over 45 years of age are generally barred from ART (Tan et al., 2014) . Sweden and Finland have cut-offs of 42 and 40 years, respectively (Gleicher et al., 2014) . One reason for the cost constrictions is the low success rate, leading doctors and policy makers to consider ART for older women "a waste of time and money" (Moolenaar et al., 2014; Ng and Ho, 2007) . Part of the reason for the low success rates for older women are cost-cutting measures that have led to the transfer of a single embryo to avoid the higher costs associated with multiple births, when older women actually require three or more embryos to be transferred to achieve reasonable livebirth rates and two or more to avoid futility Spandorfer et al., 2007) . Use of plants to improve these outcomes would thus help overcome these barriers to ART treatment. Hu et al., 2007; Kilicdag et al., 2004; Nasri et al., 2007; van Die et al., 2013; Vassiliadis, 2013; Wuttke et al., 2003 Prospective comparative Doppler study Similar effects to ethinyl oestradiol in changing the uterine artery blood flow and reducing menstrual pain (dysmenorrhoea)
Flavonoids, terpenoids, neolignans, phenolics, diterpenes and a glyceride compound Aksoy et al., 2013; Chen et al., 2011 Corpus striatum membrane dopamine (dopamine receptor binding assay in vitro)
Diterpenes are active compounds acting as dopamine agonists and inhibiting prolactin release Hu et al., 2007 Pilot study of a FertilityBlend (Daily Wellness, Honolulu, Hawaii) with 30 women After 5 months, significantly more women given the fertility blend were pregnant (five of 15 versus none in the placebo group) and four of the five women who conceived had healthy births Increase in the mean midluteal phase progesterone level (from 8.2 to 12.8 ng/ml, P = 0.08) and a significant increase in the average number of days in the luteal phase of the cycle with increased basal temperatures Clark et al., 2013; Westphal et al., 2004 FSH, follicle-stimulating hormone; LH, luteinizing hormone; PMS, premenstrual syndrome.
Several studies have indicated that some of the plants described in this paper are recommended by midwives in the USA and the UK, and these studies can provide individualized dosages to test (Hall et al., 2012) . Those herbs with a large consumer market -such as black cohosh and vitex -have been subjected to considerably more rigorous clinical and pharmacological study (see Tables 2-12 ) than more obscure herbs such as false unicorn and downy rattlesnake plantain (see Supplmentary Material Items 3-29) . The size of the consumer market for black cohosh is suggested by 2004 data from the UK-based Medicines and Healthcare Products Regulatory Agency which recorded 9 million days-worth of treatments purchased annually in capsule and tablet form (Merchant and Stebbing, 2015) .
It should also be noted that TCM has a systematic approach to diagnosis and treatment of women's reproductive health concerns dating back as early as 1237 AD with the publication of the text The Complete Book of Effective Prescriptions for Diseases of Women. Modern-day clinicians treat infertility likewise and attention is paid to signs of ovulation (e.g. cervical mucus, rise in basal body temperature) and menstruation. Timing and duration of menses, and the quality of the menstrual flow (whether it contains clots, colour of the blood, heavy or light flow) are noted, as well as associated symptoms such as dysmenorrhoea, changes in bowel habits and breast tenderness. Male factor infertility is also treated with the aim of improving sperm count, morphology and motility. An individualized differential diagnosis and treatment plan is determined and implemented for personalized patient care.
In seeking to integrate medicinal plants into infertility treatment, we are not advocating anything extraordinary as herbs are already used with and without the knowledge of the patient's doctor (Smith et al., 2010) . Hall et al. (2012) note that pregnant women already use medicinal plants to complement allopathic medicine as it gives them greater participation and control over their experience, and this control improves birth satisfaction.
The clinical trials and historical evidence discussed in this paper suggest that black cohosh can be used with IVF. Vitex could be considered for IVF patients with luteal-phase defect. Viburnum can possibly be used during critical stages of the pregnancy to prevent miscarriage. Unlike the historical case presented in this paper (Pharmacology and Therapeutics, 1888) , patients taking viburnum would have the advantage of technological fetal monitoring to ensure that they were still carrying a viable fetus. As part of further study necessary to confirm which plants are best suited to which infertility-related issue within an integrated approach with ART, the case reports of doctors in colonial America, some of which have been presented in this paper, could perhaps be collated and analysed so that they can provide guidance for current and future clinical cases and trials.
